{
  "hash": "c45c8812f67b05e5680c218cf8453e35",
  "result": {
    "engine": "knitr",
    "markdown": "---\neditor_options: \n   chunk_output_type: console\n---\n\n\n\n# ACA Federal Upper Limits {#sec-acaful}\n\n__Affordable Care Act Federal Upper Limits (FUL)__ based on the weighted average of the most recently reported monthly average manufacturer price (AMP) for pharmaceutically and therapeutically equivalent multiple source drug products that are available for purchase by retail community pharmacies on a nationwide basis.\n\n## Metadata\n\n::: {.cell}\n<pre class=\"r-output\"><code>  [ROWS] 1945283 \n [PAGES] 244 \n[FIELDS] 14 \n</code></pre>\n:::\n\n### Dictionary\n\n::: {.cell}\n<pre class=\"r-output\"><code><span style='color: #BB0000; font-weight: bold; text-decoration: underline;'>state</span>\n<span style='color: #555555;'>State.</span>\n\n<span style='color: #BB0000; font-weight: bold; text-decoration: underline;'>year</span>\n<span style='color: #555555;'>Year of TAF data.</span>\n\n<span style='color: #BB0000; font-weight: bold; text-decoration: underline;'>benefit_package</span>\n<span style='color: #555555;'>Type of Medicaid and CHIP benefit package\n(full-scope, comprehensive, limited, or unknown).</span>\n\n<span style='color: #BB0000; font-weight: bold; text-decoration: underline;'>count_ever_enrolled</span>\n<span style='color: #555555;'>Number of Medicaid and CHIP beneficiaries ever\nenrolled in each benefit package over the year\n(duplicated count).</span>\n\n<span style='color: #BB0000; font-weight: bold; text-decoration: underline;'>count_last_month_enrollment</span>\n<span style='color: #555555;'>Number of Medicaid and CHIP beneficiaries enrolled\nin each benefit package as of an individual's last\nmonth of enrollment (unduplicated count).</span>\n\n<span style='color: #BB0000; font-weight: bold; text-decoration: underline;'>average_enrollment_per_month</span>\n<span style='color: #555555;'>Average monthly enrollment in each benefit package\nover the year.</span>\n\n<span style='color: #BB0000; font-weight: bold; text-decoration: underline;'>dq_unusable</span>\n<span style='color: #555555;'>Flag for states with unusable TAF data quality or\nhigh concern data quality on one or more adapted\nmeasures based on DQ Atlas thresholds.</span>\n</code></pre>\n:::\n\n## Data\n\n::: {.cell}\n<pre class=\"r-output\"><code>tibble [8,000 Ã— 14] (S3: tbl_df/tbl/data.frame)\n $ product_group      : chr [1:8000] \"1165\" \"4486\" \"2662\" \"1912\" ...\n $ ingredient         : chr [1:8000] \"NYSTATIN\" \"OLMESARTAN MEDOXOMIL\" \"RIVASTIGMINE TARTRATE\" \"QUINAPRIL HYDROCHLORIDE\" ...\n $ strength           : chr [1:8000] \"500000U\" \"20MG\" \"3MG\" \"5MG\" ...\n $ dosage             : chr [1:8000] \"TABLET\" \"TABLET\" \"CAPSULE\" \"TABLET\" ...\n $ route              : chr [1:8000] \"ORAL\" \"ORAL\" \"ORAL\" \"ORAL\" ...\n $ mdr_unit_type      : Factor w/ 6 levels \"CAP\",\"GM\",\"ML\",..: 5 5 1 5 5 5 1 1 1 5 ...\n $ aca_ful            : num [1:8000] 0.4416 0.6728 0.3296 0.1307 0.0935 ...\n $ package_size       : int [1:8000] 100 30 500 90 90 100 90 90 100 100 ...\n $ ndc                : chr [1:8000] \"23155-0051-01\" \"68462-0437-30\" \"33342-0090-15\" \"68180-0556-09\" ...\n $ arated             : chr [1:8000] \"Yes\" \"Yes\" \"Yes\" \"Yes\" ...\n $ year               : int [1:8000] 2019 2019 2019 2019 2019 2019 2019 2019 2019 2019 ...\n $ month              : int [1:8000] 2 2 2 2 2 2 2 2 2 2 ...\n $ amp_wt_avg         : num [1:8000] 0.159 0.3845 0.0385 0.047 0.0535 ...\n $ gt_175pc_amp_wt_avg: int [1:8000] 1 0 1 1 0 0 0 0 1 1 ...\n</code></pre>\n:::\n\n### Overview\n\n::: {.cell}\n\n```{.r .cell-code}\nresp |> data_codebook()\n```\n\n<pre class=\"r-output\"><code><span style='color: #0000BB;'>resp (8000 rows and 14 variables, 14 shown)</span>\n\nID | Name                | Type        | Missings\n---+---------------------+-------------+---------\n1  | product_group       | character   | 0 (0.0%)\n   |                     |             |         \n   |                     |             |         \n   |                     |             |         \n   |                     |             |         \n   |                     |             |         \n   |                     |             |         \n   |                     |             |         \n   |                     |             |         \n   |                     |             |         \n   |                     |             |         \n---+---------------------+-------------+---------\n2  | ingredient          | character   | 0 (0.0%)\n   |                     |             |         \n   |                     |             |         \n   |                     |             |         \n   |                     |             |         \n   |                     |             |         \n   |                     |             |         \n   |                     |             |         \n   |                     |             |         \n   |                     |             |         \n   |                     |             |         \n---+---------------------+-------------+---------\n3  | strength            | character   | 0 (0.0%)\n   |                     |             |         \n   |                     |             |         \n   |                     |             |         \n   |                     |             |         \n   |                     |             |         \n   |                     |             |         \n   |                     |             |         \n   |                     |             |         \n   |                     |             |         \n   |                     |             |         \n---+---------------------+-------------+---------\n4  | dosage              | character   | 0 (0.0%)\n   |                     |             |         \n   |                     |             |         \n   |                     |             |         \n   |                     |             |         \n   |                     |             |         \n   |                     |             |         \n   |                     |             |         \n   |                     |             |         \n   |                     |             |         \n   |                     |             |         \n---+---------------------+-------------+---------\n5  | route               | character   | 0 (0.0%)\n   |                     |             |         \n   |                     |             |         \n   |                     |             |         \n   |                     |             |         \n   |                     |             |         \n   |                     |             |         \n   |                     |             |         \n   |                     |             |         \n   |                     |             |         \n   |                     |             |         \n---+---------------------+-------------+---------\n6  | mdr_unit_type       | categorical | 0 (0.0%)\n   |                     |             |         \n   |                     |             |         \n   |                     |             |         \n   |                     |             |         \n   |                     |             |         \n---+---------------------+-------------+---------\n7  | aca_ful             | numeric     | 0 (0.0%)\n---+---------------------+-------------+---------\n8  | package_size        | integer     | 0 (0.0%)\n---+---------------------+-------------+---------\n9  | ndc                 | character   | 0 (0.0%)\n   |                     |             |         \n   |                     |             |         \n   |                     |             |         \n   |                     |             |         \n   |                     |             |         \n   |                     |             |         \n   |                     |             |         \n   |                     |             |         \n   |                     |             |         \n   |                     |             |         \n---+---------------------+-------------+---------\n10 | arated              | character   | 0 (0.0%)\n   |                     |             |         \n---+---------------------+-------------+---------\n11 | year                | integer     | 0 (0.0%)\n---+---------------------+-------------+---------\n12 | month               | integer     | 0 (0.0%)\n   |                     |             |         \n---+---------------------+-------------+---------\n13 | amp_wt_avg          | numeric     | 0 (0.0%)\n---+---------------------+-------------+---------\n14 | gt_175pc_amp_wt_avg | integer     | 0 (0.0%)\n   |                     |             |         \n-------------------------------------------------\n\nID |                                 Values |             N\n---+----------------------------------------+--------------\n1  |                                  10036 |    2 (  0.0%)\n   |                                  10126 |    4 (  0.0%)\n   |                                   1019 |    4 (  0.0%)\n   |                                    102 |    5 (  0.1%)\n   |                                   1022 |    7 (  0.1%)\n   |                                   1026 |    3 (  0.0%)\n   |                                   1028 |   10 (  0.1%)\n   |                                   1029 |   11 (  0.1%)\n   |                                   1032 |    6 (  0.1%)\n   |                                   1042 |    4 (  0.0%)\n   |                                  (...) |              \n---+----------------------------------------+--------------\n2  |                       ABACAVIR SULFATE |    9 (  0.1%)\n   |            ABACAVIR SULFATE/LAMIVUDINE |    3 (  0.0%)\n   |                    ACAMPROSATE CALCIUM |    3 (  0.0%)\n   |                               ACARBOSE |   15 (  0.2%)\n   |              ACETAMINOPHEN; BUTALBITAL |    2 (  0.0%)\n   |       ACETAMINOPHEN; CODEINE PHOSPHATE |   15 (  0.2%)\n   | ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE |   27 (  0.3%)\n   |  ACETAMINOPHEN; TRAMADOL HYDROCHLORIDE |   11 (  0.1%)\n   |                          ACETAZOLAMIDE |   10 (  0.1%)\n   |                              ACITRETIN |    7 (  0.1%)\n   |                                  (...) |              \n---+----------------------------------------+--------------\n3  |                             .025MG/24H |    5 (  0.1%)\n   |                             .0375MG/24 |    3 (  0.0%)\n   |                             .075MG/24H |    1 (  0.0%)\n   |                                 0.005% |    3 (  0.0%)\n   |                                0.005MG |    3 (  0.0%)\n   |                                 0.01 % |    6 (  0.1%)\n   |                                  0.01% |    1 (  0.0%)\n   |                             0.02-3(24) |   11 (  0.1%)\n   |                                0.025MG |    3 (  0.0%)\n   |                          0.025MG;2.5MG |    7 (  0.1%)\n   |                                  (...) |              \n---+----------------------------------------+--------------\n4  |                             ADH. PATCH |    2 (  0.0%)\n   |                             CAP ER 24H |   55 (  0.7%)\n   |                             CAP SA 24H |    8 (  0.1%)\n   |                             CAP SPR 24 |   15 (  0.2%)\n   |                                CAPSULE |  892 ( 11.2%)\n   |                             CAPSULE DR |   67 (  0.8%)\n   |                             CAPSULE ER |   24 (  0.3%)\n   |           CAPSULE, DELAYED REL PELLETS |   76 (  0.9%)\n   |              CAPSULE, EXTENDED RELEASE |  119 (  1.5%)\n   |                            CONCENTRATE |    9 (  0.1%)\n   |                                  (...) |              \n---+----------------------------------------+--------------\n5  |                                 DENTAL |    1 (  0.0%)\n   |                                  NASAL |    5 (  0.1%)\n   |                             OPHTHALMIC |   38 (  0.5%)\n   |                                   ORAL | 7728 ( 96.6%)\n   |                                ORAL-28 |   41 (  0.5%)\n   |                           ORAL, RECTAL |    4 (  0.0%)\n   |                                   OTIC |    3 (  0.0%)\n   |                                 RECTAL |    7 (  0.1%)\n   |                                  SUB-Q |    4 (  0.0%)\n   |                             SUBLINGUAL |   19 (  0.2%)\n   |                                  (...) |              \n---+----------------------------------------+--------------\n6  |                                    CAP | 1300 ( 16.2%)\n   |                                     GM |   84 (  1.0%)\n   |                                     ML |  174 (  2.2%)\n   |                                    SUP |    5 (  0.1%)\n   |                                    TAB | 6374 ( 79.7%)\n   |                                    TDP |   63 (  0.8%)\n---+----------------------------------------+--------------\n7  |                            [0, 127.26] |          8000\n---+----------------------------------------+--------------\n8  |                             [1, 28000] |          8000\n---+----------------------------------------+--------------\n9  |                          00002-3231-30 |    1 (  0.0%)\n   |                          00002-3232-30 |    1 (  0.0%)\n   |                          00002-3234-30 |    1 (  0.0%)\n   |                          00002-3251-30 |    1 (  0.0%)\n   |                          00002-3270-04 |    1 (  0.0%)\n   |                          00002-4184-02 |    1 (  0.0%)\n   |                          00002-4184-07 |    1 (  0.0%)\n   |                          00002-4184-30 |    1 (  0.0%)\n   |                          00002-4456-01 |    1 (  0.0%)\n   |                          00002-4456-85 |    1 (  0.0%)\n   |                                  (...) |              \n---+----------------------------------------+--------------\n10 |                                     No |   71 (  0.9%)\n   |                                    Yes | 7929 ( 99.1%)\n---+----------------------------------------+--------------\n11 |                                   2019 | 8000 (100.0%)\n---+----------------------------------------+--------------\n12 |                                      2 | 7997 (100.0%)\n   |                                     11 |    3 (  0.0%)\n---+----------------------------------------+--------------\n13 |                             [0, 72.72] |          8000\n---+----------------------------------------+--------------\n14 |                                      0 | 4983 ( 62.3%)\n   |                                      1 | 3017 ( 37.7%)\n-----------------------------------------------------------\n</code></pre>\n:::\n\n",
    "supporting": [],
    "filters": [
      "rmarkdown/pagebreak.lua"
    ],
    "includes": {},
    "engineDependencies": {},
    "preserve": {},
    "postProcess": true
  }
}